https://www.businesswire.com/news/home/20260619241579/fr 2026-06-20T19:15:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260609901853/en/CORRECTING-and-REPLACING-Two-Prime-Earns-SOC-1-Type-2-and-SOC-2-Type-2-Designation 2026-06-20T18:37:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260620892484/en/NVCR-Investors-Have-Opportunity-to-Join-NovoCure-Limited-Fraud-Investigation-with-the-Schall-Law-Firm 2026-06-20T17:34:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260620173497/en/WLTH-Investors-Have-Opportunity-to-Join-Wealthfront-Corporation-Fraud-Investigation-with-the-Schall-Law-Firm 2026-06-20T17:34:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260620471237/en/ACN-Investors-Have-Opportunity-to-Join-Accenture-plc-Fraud-Investigation-with-the-Schall-Law-Firm 2026-06-20T17:05:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260620924931/en/BRCB-Investors-Have-Opportunity-to-Lead-Black-Rock-Coffee-Bar-Inc.-Securities-Fraud-Lawsuit-with-the-Schall-Law-Firm 2026-06-20T16:53:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260619892511/en/Greenstone-Biosciences-Inc.-and-Intel-Corp.-Launch-Strategic-Collaboration-to-Scale-Human-Centric-Drug-Discovery 2026-06-20T05:39:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260619933808/ja 2026-06-20T00:12:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260619169163/pt 2026-06-20T00:07:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260619132573/it 2026-06-20T00:03:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260619159358/zh-HK 2026-06-20T00:00:00.000Z weekly 0.5